title: Diagnosis and treatment of impulse control disorders in patients with movement disorders.
abstract: Impulse control disorders are a psychiatric condition characterized by the failure to resist an impulsive act or behavior that may be harmful to self or others. In movement disorders, impulse control disorders are associated with dopaminergic treatment, notably dopamine agonists (DAs). Impulse control disorders have been studied extensively in Parkinson's disease, but are also recognized in restless leg syndrome and atypical Parkinsonian syndromes. Epidemiological studies suggest younger age, male sex, greater novelty seeking, impulsivity, depression and premorbid impulse control disorders as the most consistent risk factors. Such patients may warrant special monitoring after starting treatment with a DA. Various individual screening tools are available for people without Parkinson's disease. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease has been developed specifically for Parkinson's disease. The best treatment for impulse control disorders is prevention. However, after the development of impulse control disorders, the mainstay intervention is to reduce or discontinue the offending anti-Parkinsonian medication. In refractory cases, other pharmacological interventions are available, including neuroleptics, antiepileptics, amantadine, antiandrogens, lithium and opioid antagonists. Unfortunately, their use is only supported by case reports, small case series or open-label clinical studies. Prospective, controlled studies are warranted. Ongoing investigations include naltrexone and nicotine.
authors: Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
authors: Tiago A
authors: TA
authors: Mestre
authors: Antonio P
authors: AP
authors: Strafella
authors: Teri
authors: T
authors: Thomsen
authors: Valerie
authors: V
authors: Voon
authors: Janis
authors: J
authors: Miyasaki
keywords: Impulse control disorders; Parkinson’s disease; dopamine agonist; neurobehavioural; non-motor complication; parkinsonism; restless leg syndrome
references: Psychiatry Res. 2009 Mar 31;166(1):76-84
references: 19200607
references: Biol Psychiatry. 1994 Sep 1;36(5):350-1
references: 7993965
references: Ann Neurol. 2010 Sep;68(3):400-4
references: 20687121
references: Mov Disord. 2006 Nov;21(11):1941-6
references: 16972268
references: J Clin Psychiatry. 1994 Jun;55(6):242-8
references: 8071278
references: Mov Disord. 2006 Apr;21(4):524-9
references: 16261618
references: Mov Disord. 2010 Jan 30;25(2):221-3
references: 20077470
references: J Clin Psychiatry. 2005 May;66(5):564-74
references: 15889941
references: Mov Disord. 2010 Nov 15;25(15):2649-53
references: 21069833
references: Sleep Med. 2009 Apr;10(4):494-6
references: 19410183
references: Ann Neurol. 2010 Dec;68(6):963-8
references: 21154480
references: Mov Disord. 2007 Jun 15;22(8):1179-81
references: 17230464
references: Ann Neurol. 2004 Jun;55(6):871-5
references: 15174022
references: Parkinsonism Relat Disord. 2004 Mar;10(3):177-80
references: 15036174
references: Neurology. 2010 Nov 9;75(19):1711-6
references: 20926784
references: Mov Disord. 2003 May;18(5):510-4
references: 12722164
references: Mov Disord. 2004 Apr;19(4):433-7
references: 15077241
references: Neurology. 2006 Oct 10;67(7):1258-61
references: 17030761
references: Parkinsonism Relat Disord. 2008;14(3):257-8
references: 17561433
references: Ann Neurol. 2011 Jun;69(6):986-96
references: 21416496
references: Sleep. 2010 Jan;33(1):81-7
references: 20120624
references: Semin Clin Neuropsychiatry. 2001 Jul;6(3):177-83
references: 11447569
references: J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):56-62
references: 21304139
references: Clin Neuropharmacol. 2012 Nov-Dec;35(6):261-5
references: 23123689
references: Arch Neurol. 2011 Apr;68(4):544-5; author reply 545-6
references: 21482941
references: Neurology. 2006 Oct 10;67(7):1254-7
references: 16957130
references: Mov Disord. 2007 Mar 15;22(4):590-1
references: 17230484
references: Psychiatr Neurol Neurochir. 1972 May-Jun;75(3):203-12
references: 4625014
references: BMC Neurol. 2011 Sep 28;11:117
references: 21955669
references: Mov Disord. 2010 Nov 15;25(15):2641-8
references: 20836134
references: Int J Eat Disord. 2011 Jan;44(1):81-90
references: 21080416
references: Neurobiol Dis. 2010 Jul;39(1):98-104
references: 20338240
references: Sleep Med. 2011 Dec;12(10):1003-7
references: 22000419
references: J Neurol. 2011 Apr;258(4):656-60
references: 21072531
references: Arch Neurol. 2007 Feb;64(2):212-6
references: 17296836
references: Mov Disord. 1999 Sep;14(5):836-8
references: 10495047
references: J Clin Neurosci. 2007 Dec;14(12):1178-81
references: 17720504
references: Ann N Y Acad Sci. 2008 Oct;1142:85-107
references: 18990123
references: Parkinsonism Relat Disord. 2005 Sep;11(6):381-6
references: 16109498
references: J Neuropsychiatry Clin Neurosci. 2008 Fall;20(4):496-7
references: 19196941
references: J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):130-5
references: 22933817
references: Ann Pharmacother. 2002 Jul-Aug;36(7-8):1178-9
references: 12086551
references: Mov Disord. 2010 Apr 15;25(5):638-42
references: 20213825
references: J Neurol Neurosurg Psychiatry. 2007 May;78(5):517-9
references: 17210626
references: CNS Spectr. 2008 Aug;13(8):690-8
references: 18704024
references: J Neurol Sci. 2011 Nov 15;310(1-2):197-201
references: 21683375
references: Arch Sex Behav. 2010 Apr;39(2):377-400
references: 19937105
references: Mov Disord. 2007 Sep 15;22(12):1757-63
references: 17580327
references: Arch Neurol. 2006 Jul;63(7):969-73
references: 16831966
references: J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8
references: 10727476
references: Parkinsonism Relat Disord. 2007 Dec;13(8):535-6
references: 17270485
references: J Clin Psychopharmacol. 2007 Feb;27(1):107-8
references: 17224732
references: Mov Disord. 2009 Jan 15;24(1):140-1
references: 18855926
references: PLoS One. 2012;7(1):e29768
references: 22295068
references: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1009-13
references: 21324349
references: Brain. 2005 Oct;128(Pt 10):2240-9
references: 15975946
references: J Neurol. 2010 Oct;257(10):1682-5
references: 20509031
references: J Gambl Stud. 1994 Dec;10(4):339-62
references: 24234969
references: J Clin Neurosci. 2010 Apr;17(4):539-40
references: 20171891
references: Mov Disord. 2011 Oct;26 Suppl 3:S42-80
references: 22021174
references: Mov Disord. 2010 Nov 15;25(15):2634-40
references: 20669306
references: J Clin Psychiatry. 1994 Jan;55(1):5-11
references: 8294395
references: Parkinsonism Relat Disord. 2007 Dec;13(8):516-9
references: 17544807
references: Mov Disord. 2008 Jan;23(1):75-80
references: 17960796
references: Mov Disord. 2009 Jul 30;24(10):1461-7
references: 19452562
references: J Clin Psychopharmacol. 2012 Jun;32(3):424-5
references: 22534502
references: Parkinsonism Relat Disord. 2012 Feb;18(2):207-9
references: 22030321
references: Mov Disord. 2008 Jan;23(1):129-30
references: 17960816
references: Clin Neuropharmacol. 1989 Oct;12(5):375-83
references: 2575449
references: Am J Psychiatry. 1987 Sep;144(9):1184-8
references: 3631315
references: Mov Disord. 2006 Dec;21(12):2214-7
references: 17013916
references: Neurology. 1996 Sep;47(3):626-35
references: 8797455
references: Mov Disord. 2006 Aug;21(8):1217-8
references: 16637024
references: Int J Gen Med. 2009 Jul 30;2:57-61
references: 20360887
references: Mov Disord. 2010 Jun 15;25(8):1026-33
references: 20131391
references: J Clin Neurosci. 2009 Sep;16(9):1148-52
references: 19553125
references: Rev Neurol (Paris). 2009 Nov;165(11):845-56
references: 19683776
references: Br J Psychiatry. 1983 Mar;142:296-8
references: 6860883
references: Mov Disord. 2009 Dec 15;24(16):2430-1
references: 19908308
references: Parkinsonism Relat Disord. 2008;14(5):448-9
references: 18339573
references: Clin Neuropharmacol. 2012 May-Jun;35(3):118-20
references: 22426027
references: Brain. 2009 May;132(Pt 5):1376-85
references: 19346328
references: Mov Disord. 2012 Feb;27(2):242-7
references: 22134954
references: Mov Disord. 2008 Feb 15;23(3):411-5
references: 18067187
references: Am J Ther. 2005 Sep-Oct;12(5):467-8
references: 16148432
references: Parkinsonism Relat Disord. 2006 Sep;12(6):392-5
references: 16730214
references: Br J Psychiatry. 2010 Oct;197(4):330-1
references: 20884959
references: Mov Disord. 2004 Apr;19(4):397-405
references: 15077237
references: Parkinsonism Relat Disord. 2011 Mar;17(3):153-5
references: 21186135
references: Curr Treat Options Neurol. 2007 May;9(3):189-97
references: 17445496
references: Mov Disord. 2005 Jan;20(1):77-81
references: 15390130
references: Arch Neurol. 2010 Jan;67(1):58-63
references: 20065130
references: J Gambl Stud. 2005 Winter;21(4):431-43
references: 16311876
references: Clin Neuropharmacol. 2001 May-Jun;24(3):170-2
references: 11391129
references: Parkinsonism Relat Disord. 2011 Jun;17(5):379-81
references: 21459656
references: Neurology. 2005 Nov 22;65(10):1570-4
references: 16301483
references: Mov Disord. 1998 May;13(3):597-8
references: 9613761
references: Arch Neurol. 2010 May;67(5):589-95
references: 20457959
references: Am J Psychiatry. 2006 Oct;163(10):1806-12
references: 17012693